What is Poly‑Iron 150 Forte (oral iron supplement) and how should it be dosed, including its indications, contraindications, and precautions?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Poly-Iron 150 Forte: Oral Iron Supplement Overview

Poly-Iron 150 Forte is an oral iron supplement containing 150 mg of elemental iron as polysaccharide iron complex, dosed once daily in adults for treating iron deficiency anemia. 1

Product Specifications

Active Ingredient:

  • 150 mg elemental iron as polysaccharide iron complex per capsule 1

Standard Dosing:

  • Adults only: One capsule daily 1
  • Take at 0800h (morning) on an empty stomach for optimal absorption 2, 3
  • Do not exceed recommended dosage 1

Indications

Poly-Iron 150 Forte is indicated for:

  • Treatment of iron deficiency anemia (IDA) in adults
  • Replenishment of iron stores
  • Patients with mild anemia (Hb 11.0-12.9 g/dL in men, 11.0-11.9 g/dL in women) and clinically inactive disease 4

Key consideration: Oral iron is most appropriate for patients with mild anemia, clinically inactive disease, and no prior intolerance to oral iron 4. For moderate-to-severe anemia (Hb <100 g/L) or active inflammatory conditions, intravenous iron should be considered first-line 4, 5.

Contraindications and Precautions

Contraindications:

  • Pregnancy and breastfeeding require consultation with healthcare professional 1
  • Active inflammatory bowel disease (oral iron may exacerbate disease activity) 4

Critical Warnings:

  • Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6 1
  • Keep out of reach of children

Drug Interactions:

  • Do not take within 2 hours of tetracycline antibiotics (iron interferes with tetracycline absorption) 1
  • Avoid concurrent use with calcium supplements, antacids, H2 inhibitors, and proton pump inhibitors (all reduce iron absorption) 2

Common Side Effects:

  • Gastrointestinal discomfort (nausea, constipation, diarrhea) - minimize by taking with meals 1
  • Black stools (benign but expected) 1
  • Constipation occurs in ~12% of patients 6

Optimal Dosing Strategy

For Maximum Absorption:

  1. Timing: Take in the morning (0800h ± 1 hour) on an empty stomach 2, 3, 7

  2. Frequency: Recent evidence strongly supports alternate-day dosing over daily dosing 3, 7, 8:

    • Daily iron doses ≥60 mg stimulate hepcidin elevation that persists 24 hours, reducing absorption of subsequent doses
    • Alternate-day dosing increases fractional iron absorption by 40-50% compared to consecutive daily dosing 7, 8
    • Consider taking 150 mg every other day rather than daily for improved absorption and tolerability
  3. Co-administration:

    • Take with 100 mg vitamin C (tablet or citrus juice) to enhance absorption 2, 3
    • If vitamin C unavailable, take with plain water 2
    • Avoid taking with food, milk, tea, or coffee (markedly reduces absorption) 2
  4. Pill Esophagitis Prevention:

    • Take with a full glass of liquid
    • Remain upright (do not recline) for 30-60 minutes after dosing 2

Monitoring and Follow-up

Expected Response:

  • Hemoglobin should increase by 1 g/dL within 2-4 weeks 9, 6
  • Ferritin should increase within 1 month 6

Monitoring Schedule:

  • Check hemoglobin at 4 weeks to assess response 9
  • Continue treatment for 3 months after normalization of hemoglobin to replenish iron stores 10, 9
  • Monitor every 3 months for first year after correction, then every 6-12 months 4

Failure to Respond:

If no improvement in hemoglobin or ferritin after 4 weeks, assess for:

  • Non-adherence due to side effects
  • Malabsorption (celiac disease, inflammatory bowel disease, post-bariatric surgery)
  • Ongoing blood loss exceeding oral iron replacement capacity
  • Switch to intravenous iron if oral iron fails 11, 6

When to Use Intravenous Iron Instead

Intravenous iron is preferred over oral iron in:

  • Active inflammatory bowel disease with moderate-to-severe anemia (Hb <100 g/L) 4
  • Previous intolerance to oral iron 4, 9
  • Failure to respond to adequate trial of oral iron 9, 6
  • Malabsorption syndromes (celiac disease, post-gastric surgery) 11, 6
  • Chronic kidney disease 12, 13
  • Heart failure with iron deficiency 12, 14
  • When blood loss exceeds capacity for oral replacement 11

Special Populations

Inflammatory Bowel Disease:

  • Maximum 100 mg elemental iron daily in IBD patients 4, 5
  • Oral iron should only be used in clinically inactive disease 4, 5
  • Luminal iron may exacerbate disease activity and alter intestinal microbiota 4

Premenopausal Women:

  • Consider menstrual blood loss as primary cause
  • Gastrointestinal evaluation may be deferred in young women with obvious menstrual losses and response to iron 11

Treatment Supervision

All anemic conditions should be treated under medical supervision 1. The 150 mg dose in Poly-Iron 150 Forte exceeds the recommended maximum of 100 mg elemental iron daily for certain populations (particularly IBD patients) 4, 5, so clinical judgment regarding appropriateness is essential.

References

Research

Dosing Patients With Oral Iron Supplements: Practical Guidance.

The Journal of clinical psychiatry, 2025

Guideline

management of anemia in patients with congestive heart failure.

American Journal of Hematology, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.